Poly(ADP-ribose) polymerase (PARP) proteins help mediate effective DNA damage responses, and PARP inhibitors hold promise for the treatment of breast cancer by inhibiting this repair process (225). This evidence concerns the gene PARP1 and breast carcinoma.